Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy

被引:56
作者
Cohen, N [1 ]
Muntoni, F [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Dubowitz Neuromuscular Unit, London W12 0NN, England
关键词
D O I
10.1136/hrt.2003.023390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
X linked dilated cardiomyopathy is a familial disease that is allelic to Duchenne and Becker muscular dystrophies and caused by mutations in the dystrophin gene. In several families with X linked dilated cardiomyopathy, the pattern of expression of dystrophin mutations in cardiac muscle differs from that in skeletal muscle. A number of these mutations affect transcription and splicing of the dystrophin gene in a tissue specific manner; others may affect regions of dystrophin that are presumed to have a more important role in cardiac than in skeletal muscle. These mutations are important because they highlight the fundamental differences in processing of the dystrophin gene between skeletal and cardiac tissues, as well as differences in the functional domains more relevant for one tissue or the other. This review focuses on the major mechanisms that have been proposed to explain this disorder.
引用
收藏
页码:835 / 841
页数:7
相关论文
共 70 条
[1]   Biochemistry and regulation of pre-mRNA splicing [J].
Adams, MD ;
Rudner, DZ ;
Rio, DC .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (03) :331-339
[2]   THE STRUCTURAL AND FUNCTIONAL DIVERSITY OF DYSTROPHIN [J].
AHN, AH ;
KUNKEL, LM .
NATURE GENETICS, 1993, 3 (04) :283-291
[3]   A NEW PHENOTYPE (MCLEOD) IN KELL BLOOD-GROUP SYSTEM [J].
ALLEN, FH ;
KRABBE, SMR ;
CORCORAN, PA .
VOX SANGUINIS, 1961, 6 (05) :555-&
[4]   Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy [J].
Arbustini, E ;
Diegoli, M ;
Morbini, P ;
Dal Bello, B ;
Banchieri, N ;
Pilotto, A ;
Magani, F ;
Grasso, M ;
Narula, J ;
Gavazzi, A ;
Viganò, N ;
Tavazzi, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (07) :1760-1768
[5]   Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue [J].
Badorff, C ;
Berkely, N ;
Mehrotra, S ;
Talhouk, JW ;
Rhoads, RE ;
Knowlton, KU .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :11191-11197
[6]   Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy [J].
Badorff, C ;
Lee, GH ;
Lamphear, BJ ;
Martone, ME ;
Campbell, KP ;
Rhoads, RE ;
Knowlton, KU .
NATURE MEDICINE, 1999, 5 (03) :320-326
[7]   A web-accessible complete transcriptome of normal human and DMD muscle [J].
Bakay, M ;
Zhao, P ;
Chen, J ;
Hoffman, EP .
NEUROMUSCULAR DISORDERS, 2002, 12 :S125-S141
[8]   AN X-LINKED MITOCHONDRIAL DISEASE AFFECTING CARDIAC-MUSCLE, SKELETAL-MUSCLE AND NEUTROPHIL LEUKOCYTES [J].
BARTH, PG ;
SCHOLTE, HR ;
BERDEN, JA ;
VANDERKLEIVANMOORSEL, JM ;
LUYTHOUWEN, IEM ;
VANTVEERKORTHOF, ET ;
VANDERHARTEN, JJ ;
SOBOTKAPLOJHAR, MA .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 62 (1-3) :327-355
[9]   A novel muscle-specific enhancer identified within the deletion overlap region of two XLDC patients lacking muscle exon 1 of the human dystrophin gene [J].
Bastianutto, C ;
De Visser, M ;
Muntoni, F ;
Klamut, HJ ;
Patarnello, T .
GENOMICS, 2002, 80 (06) :614-620
[10]   Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy [J].
Bastianutto, C ;
Bestard, JA ;
Lahnakoski, K ;
Broere, D ;
De Visser, M ;
Zaccolo, M ;
Pozzan, T ;
Ferlini, A ;
Muntoni, F ;
Patarnello, T .
HUMAN MOLECULAR GENETICS, 2001, 10 (23) :2627-2635